MetaCap

Takeda Pharmaceutical (TAK) vs Vertex Pharmaceuticals (VRTX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Takeda Pharmaceutical (TAK) has outperformed Vertex Pharmaceuticals (VRTX) over the past year, gaining 52.2% versus a gain of 20.7%. Over five years, VRTX leads with a +180.5% price change compared with +60.9% for TAK. Vertex Pharmaceuticals is the larger company by market cap ($130.58 billion vs $69.55 billion), about 1.9 times the size.

On valuation, Vertex Pharmaceuticals trades at a lower forward P/E (25.9x vs 41.1x for Takeda Pharmaceutical). Takeda Pharmaceutical pays a dividend yielding 927.88%, while Vertex Pharmaceuticals does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

TAK+52.24%VRTX+20.68%
+55%+26%-3%
Nov 21, 20251 yearNov 20, 2026
TAK+55.39%VRTX+181.62%
+216%+98%-21%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

TAK versus VRTX key metrics
MetricTAKVRTX
Share price$21.77$515.02
Market cap$69.55B$130.58B
1-day change+1.68%-1.08%
YTD return+39.64%+13.60%
1-year return+52.24%+20.68%
5-year return+60.90%+180.53%
P/E ratio (TTM)311.0033.14
Forward P/E41.0825.86
EPS (TTM)$0.07$15.54
Dividend yield927.88%0.00%
Annual dividend$202.00$0.00
Revenue (latest FY)—$12.00B
Revenue growth (YoY)—+8.90%
Net income (latest FY)—$3.95B
Gross margin—86.24%
Operating margin—34.77%
Net margin—32.94%
52-week high$22.07$568.67
52-week low$14.16$412.27
Distance from 52-week high-1.36%-9.43%
Analyst consensusstrong_buybuy
Avg. price target upside+12.68%+15.60%
Average volume2.73M1.25M
Shares outstanding3.19B253.54M
Employees47,0296,400
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TAK has outperformed VRTX by 31.6 percentage points over the past year.
  • Takeda Pharmaceutical trades at a higher earnings multiple (311.0x vs 33.1x trailing P/E).
  • Takeda Pharmaceutical offers a meaningfully higher dividend yield (927.88% vs 0.00%).

About Takeda Pharmaceutical

TAK stock →

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Health Care · Biotechnology: Pharmaceutical Preparations · 47,029 employees

About Vertex Pharmaceuticals

VRTX stock →

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain.

Health Care · Biotechnology: Pharmaceutical Preparations · 6,400 employees

TAK vs VRTX FAQ

Which is bigger, Takeda Pharmaceutical or Vertex Pharmaceuticals?

Vertex Pharmaceuticals (VRTX) is larger, with a market capitalization of $130.58B compared with $69.55B for Takeda Pharmaceutical (TAK).

Which stock has performed better over the past year, TAK or VRTX?

TAK returned +52.24% over the past 12 months, compared with +20.68% for VRTX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, TAK or VRTX?

VRTX has the lower trailing P/E at 33.1, versus 311.0 for TAK. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Takeda Pharmaceutical or Vertex Pharmaceuticals?

Takeda Pharmaceutical pays a dividend yielding 927.88%, while Vertex Pharmaceuticals does not currently pay a regular dividend.

Are Takeda Pharmaceutical and Vertex Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons